The Pharmacy Times® Respiratory Syncytial Virus Resource Center is a comprehensive source for clinical news and expert insights on treating and preventing respiratory syncytial virus.
October 22nd 2024
New ACIP recommendations provide clarity, but questions linger for those aged 60 to 74 years.
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccin...
1.25 Credits / Immunization, Infectious Diseases
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Non-adjuvant RSV Vaccine in Older Adults
June 25th 2024An RSV medical expert provides an overview of the RENOIR trial, which investigated the efficacy and safety of an adjuvanted RSV vaccine in adults aged 60 years and older, focusing on the vaccine's effectiveness in preventing RSV-associated lower respiratory tract infections and presenting other crucial findings from the study.
Watch
Adjuvant RSV Vaccine in Older Adults
June 25th 2024Carrie Koenigsfeld, PharmD, FAPhA, reviews the pivotal findings from the AReSVi-006 trial that supported the approval of the adjuvanted RSV vaccine, including its efficacy in preventing lower respiratory tract RSV, associated adverse events, and important study limitations that may have influenced the results.
Watch
CDC Evaluates Concerns of Guillain-Barré Syndrome Following RSV Vaccination
June 17th 2024Data show that among individuals 60 years and older, the estimated rate of Guillain-Barré syndrome (GBS) after receiving an RSV vaccine was 5.0 and 1.5 per million doses of Abrysvo and Arexvy, respectively.
Read More
FDA Grants Emergency Use Authorization for 4-in-1 Respiratory Diagnostic Test
June 11th 2024The 4-in-1 respiratory diagnostic test is either a single nasopharyngeal or anterior nasal swab that can confirm or rule out SARS-CoV-2, influenza A virus, influenza B virus, and respiratory syncytial virus with a single test.
Read More
Key Considerations for Pharmacists Administering RSV Vaccines
The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.
Watch
The Pharmacist's Role in Shared Decision-Making for RSV Vaccination
Medical experts highlight the importance of clinical decision-making and the pivotal role pharmacies play in initiating conversations and identifying high-risk patients during consultations for new medications.
Watch
Challenges of Concurrent Administration: RSV and Other Vaccines
May 21st 2024The panelists address the challenges of administering multiple vaccines to eligible patients, while also discussing the timing and compatibility of administering certain vaccines simultaneously. They emphasize the importance of being receptive to patient concerns and providing guidance on childhood vaccinations for hesitant individuals.
Watch
Raising RSV Awareness Among High-Risk Patient Populations
May 21st 2024Lauren Angelo, PharmD, MBA, acknowledges the progress made in RSV vaccinations but emphasizes the persistent need to educate at-risk patients about the advantages of vaccination, citing data indicating that many patients are willing to get vaccinated but may require encouragement, and concurs that the lack of physician referral remains a crucial barrier to improving vaccination rates among high-risk groups.
Watch
Impact of Social Determinants of Health on Respiratory Syncytial Virus (RSV)
May 14th 2024Medical professionals explore social determinants of health, including access to and quality of health care, information sources, community context, and built environment, while also examining the influence of race, ethnicity, language on these factors.
Watch